Iopanoic acid in the management of neonatal graves' disease

Journal of Perinatology

Volumn 24, Issue 2, 2004, Pages 105-108

  Earles, Sonja M ^a   Gerrits, Peter M ^a,b   Transue, David J ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CONTRAST MEDIUM; DIGITALIS; IODINE; IOPANOIC ACID; LEVOTHYROXINE; LIOTHYRONINE; PROPRANOLOL; PROPYLTHIOURACIL; SEDATIVE AGENT; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROXINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; CHILD CARE; CLINICAL FEATURE; DOSE RESPONSE; DRUG ERUPTION; DRUG METABOLISM; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; INFANT; NAUSEA; RISK ASSESSMENT; SIDE EFFECT; THYROTOXICOSIS; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CONTRAST MEDIA; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; INFANT, NEWBORN; IOPANOIC ACID; PROPRANOLOL;

EID: 1642527933     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211046     Document Type: Article

References (19)

1. Fisher DA. The thyroid In: Kaplan SA, editor. Clinical Pediatric Endocrinology. Philadelphia; PA:WB Saunders; 1990. p. 114-5.
2. Transue D, Chan J, Kaplan M. Management of neonatal Graves' disease with iopanoic acid. J Pediatr 1992;121:472-4.
3. Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983;57:1036-40.
4. Karpman BA, Rapoport B, Filetti S, Fisher DA. Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. J Clin Endocrinol Metab 1987;64:119-23.
5. Petersen S, Serup J. Neonatal thyrotoxicosis. Acta Paediatr Scand 1977;66:639-42.
6. Cove DH, Johnston P. Fetal hyperthyroidism: Experience of treatment in four siblings. Lancet 1985;1:430-2.
7. Erenberg A, Phelps D, Lam R, Fisher DA. Total and free thyroid hormone concentrations in the neonatal peroid. Pediatrics 1974;53:211-6.
8. Abuid JL, Klein AH, Foley Jr TP, Larson PR. Total and free tridothyronine and thyroxine in early infancy. J Clin Endocrinol Metab 1974;39:263-8.
9. Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 1981;304:702-2.
10. Wu S, Chopra IJ, Solomon DH, Bennett LR. Changes in circulating iodothyronines in euthyroid and hyperthyrid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 1978;46:691-7.
11. Chopra IJ, Van Herle AJ, Koreman SG, Viosca S, Younai S. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocrinol Metab 1995;80:2178-80.
12. DeGroot LJ, Rue PA. Roentgenographic contrast inhibit triiodothyronine binding to nuclear receptors in vitro. J Clin Endocrinol Metab 1979;49:538-42.
13. Kohrle J, Hesch RD, Loenard JL, Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. 6th ed. Philadelphia, PA: JB Lippincott; 1991. p. 144-89.
14. Wu S, Chopra IJ, Solomon DH, Johnson DE. The effect of repeated administration of ipodate(Oragrafin) in hyperthyroidism. J Clin Endocrinol Metab 1978;47:1358-62.
15. Bürgi H, Wimpfheimer C, Burger A, Zaunbauer W, Rösler H, Lemarchand-Béraud T. Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 1976;43:1203-10.
16. Wu S, Shyh T, Chopra IJ, Solomon DH, Huang H, Chu P. Comparison of sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J Clin Endocrinol Meteb 1982;54:630-4.
17. Sharp B, Reed AW, Tamagna El, Geffner DL, Hershman JM. Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol. J Clin Endocrinol Metab 1981;53:622-5.
18. Shen D, Wu S, Chopra IJ, et al. Long term treatment of Graves' hyperthyroidism with sodium ipodate. J Clin Endocrinol Metab 1985;61:723-7.
19. Wang Y, Tsou C, Lin W, Hershman JM Long term treatment of Graves' disease with iopnoic acid (telepaque). J Clin Endocrinol Metab 1987;65:679-82.